Anxiety In Cancer Patients During F-18-Fdg Pet/Ct Low Dose: A Comparison Of Anxiety Levels Before And After Imaging Studies

Objective. Assessing the level of anxiety in oncology patients who underwent F-18-FDG PET/CT low dose scan and identifying the main reasons that generate anxiety. Material and Method. The study included 81 cancer patients submitted to the F-18-FDG PET/CT low dose scan. Patients filled in the Scan Experience Questionnaire and the State-Trait Anxiety Inventory (STAI) before and after F-18-FDG PET/CT low dose scan. Results. Substantial levels of anxiety were detected both before and after F-18-FDG PET/CT low dose scan (STAI mean > 30), with a significant increase in the state of anxiety after scan performance (p. < 0.0001, Median(pre) -31.1, and Median(pos) = 33.0). F-18-FDG PET/CT low dose results are the main cause of anxiety both before (79.1%) and after (86.9%) the scan. The information provided by staff both before and on the F-18-FDG PET/CT low dose day was classified mostly as completely understandable (70.5% and 75.3%, resp.) and as very useful (70.5% and 72.6%, resp.) and correlated positively with patients' overall satisfaction with NM Department (r(s) = 0.372, p = 0.004 and r(s) = 0.528, p = 0.000, resp.), but not with anxiety levels. Conclusions. Patients perceive high levels of anxiety during the F-18-FDG PET/CT low dose scan and the concern with scan results was pointed out as the main factor for that emotional reaction.